MedTrace Logo

Clinical Results of a Monofocal Aspheric Bitoric Intraocular Lens With Plate Haptics in Hyperopic Eyes (HIPER-AT-TORBI)

NCT05058274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-03-22

No results posted yet for this study

Summary

Observational post-marketing study with prospective follow-up of CE marked medical devices aimed at the treatment of hyperopia and astigmatism in patients with cataract. The objective is to evaluate the clinical results of the implantation of the monofocal aspheric bitoric intraocular lens (IOL) with AT-TORBI 709 plate haptics in cataract surgery of hyperopic eyes with astigmatism.

Conditions

  • Astigmatism
  • Far Sightedness
  • Cataracts

Interventions

DEVICE

Implant of the AT-TORBI 709 lens

Implant of the AT-TORBI 709 lens

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    collaborator INDUSTRY

  • OFTALVIST (Oftalmología Vistahermosa S.L)

    lead INDUSTRY

Principal Investigators

  • Pedro Tañá Rivero, Doctor · OFTALVIST (Oftalmología Vistahermosa S.L)

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-03
Primary Completion
2024-02-21
Completion
2024-02-21

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05058274 on ClinicalTrials.gov